Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Non-Current Assets (2016 - 2025)

Mimedx's Non-Current Assets history spans 15 years, with the latest figure at $65.2 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 9.51% year-over-year to $65.2 million; the TTM value through Dec 2025 reached $270.6 million, down 10.62%, while the annual FY2025 figure was $65.2 million, 9.51% down from the prior year.
  • Non-Current Assets for Q4 2025 was $65.2 million at Mimedx, roughly flat from $64.9 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $82.8 million in Q1 2024 and bottomed at -$154.5 million in Q3 2023.
  • The 5-year median for Non-Current Assets is $40.2 million (2021), against an average of $8.5 million.
  • The largest annual shift saw Non-Current Assets plummeted 475.01% in 2023 before it skyrocketed 153.93% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $39.4 million in 2021, then dropped by 5.52% to $37.2 million in 2022, then soared by 100.86% to $74.8 million in 2023, then fell by 3.69% to $72.0 million in 2024, then fell by 9.51% to $65.2 million in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Non-Current Assets are $65.2 million (Q4 2025), $64.9 million (Q3 2025), and $70.2 million (Q2 2025).